October 17, 2019 / 1:39 AM / a month ago

BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy

Oct 17 (Reuters) - Mesoblast:

* CO & LONZA ENTER AGREEMENT FOR COMMERCIAL MANUFACTURE OF MESOBLAST’S POTENTIAL FIRST UNITED STATES ALLOGENEIC CELL THERAPY

* EXPECTS TO COMPLETE FILING OF ROLLING BIOLOGICS LICENSE APPLICATION SUBMISSION TO US FDA BY THE END OF THIS YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below